|
1
|
IJspeert JE, Vermeulen L, Meijer GA and
Dekker E: Serrated neoplasia-role in colorectal carcinogenesis and
clinical implications. Nat Rev Gastroenterol Hepatol. 12:401–409.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fessler E, Drost J, van Hooff SR,
Linnekamp JF, Wang X, Jansen M, De Sousa E, Melo F, Prasetyanti PR,
IJspeert JE, et al: TGFβ signaling directs serrated adenomas to the
mesenchymal colorectal cancer subtype. EMBO Mol Med. 8:745–760.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guinney J, Dienstmann R, Wang X, de
Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda
G, Angelino P, et al: The consensus molecular subtypes of
colorectal cancer. Nat Med. 21:1350–1356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bramsen JB, Rasmussen MH, Ongen H,
Mattesen TB, Ørntoft MW, Árnadóttir SS, Sandoval J, Laguna T, Vang
S, Øster B, et al: Molecular-subtype-specific biomarkers improve
prediction of prognosis in colorectal cancer. Cell Rep.
19:1268–1280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gehren AS, Rocha MR, de Souza WF and
Morgado-Díaz JA: Alterations of the apical junctional complex and
actin cytoskeleton and their role in colorectal cancer progression.
Tissue Barriers. 3:e10176882015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lingaraju A, Long TM, Wang Y, Austin JR II
and Turner JR: Conceptual barriers to understanding physical
barriers. Semin Cell Dev Biol. 42:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zihni C, Mills C, Matter K and Balda MS:
Tight junctions: From simple barriers to multifunctional molecular
gates. Nat Rev Mol Cell Biol. 17:564–580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Oliveira SS, de Oliveira IM, De Souza W
and Morgado-Díaz JA: Claudins upregulation in human colorectal
cancer. FEBS Lett. 579:6179–6185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krug SM, Schulzke JD and Fromm M: Tight
junction, selective permeability, and related diseases. Semin Cell
Dev Biol. 36:166–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Sun T, Sun H, Yang S, Li D and
Zhou D: SCF/C-Kit/JNK/AP-1 signaling pathway promotes claudin-3
expression in colonic epithelium and colorectal carcinoma. Int J
Mol Sci. 18:7652017. View Article : Google Scholar
|
|
12
|
de Souza WF, Fortunato-Miranda N, Robbs
BK, de Araujo WM, de-Freitas-Junior JC, Bastos LG, Viola JP and
Morgado-Díaz JA: Claudin-3 overexpression increases the malignant
potential of colorectal cancer cells: Roles of ERK1/2 and PI3K-Akt
as modulators of EGFR signaling. PLoS One. 8:e749942013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh AB and Harris RC: Epidermal growth
factor receptor activation differentially regulates claudin
expression and enhances transepithelial resistance in madin-darby
canine kidney cells. J Biol Chem. 279:3543–3552. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ikari A, Sato T, Watanabe R, Yamazaki Y
and Sugatani J: Increase in claudin-2 expression by an
EGFR/MEK/ERK/c-fos pathway in lung adenocarcinoma A549 cells.
Biochim Biophys Acta. 1823:1110–1118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Campbell HK, Maiers JL and DeMali KA:
Interplay between tight junctions & adherens junctions. Exp
Cell Res. 358:39–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nita-Lazar M, Rebustini I, Walker J and
Kukuruzinska MA: Hypoglycosylated E-cadherin promotes the assembly
of tight junctions through the recruitment of PP2A to adherens
junctions. Exp Cell Res. 316:1871–1884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernandes H, Cohen S and Bishayee S:
Glycosylation-induced conformational modification positively
regulates receptor- receptor association: A study with an aberrant
epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in
cancer cells. J Biol Chem. 276:5375–5383. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Whitson KB, Whitson SR, Red-Brewer ML,
McCoy AJ, Vitali AA, Walker F, Johns TG, Beth AH and Staros JV:
Functional effects of glycosylation at asn-579 of the epidermal
growth factor receptor. Biochemistry. 44:14920–14931. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaszuba K, Grzybek M, Orłowski A, Danne R,
Róg T, Simons K, Coskun Ü and Vattulainen I: N-Glycosylation as
determinant of epidermal growth factor receptor conformation in
membranes. Proc Natl Acad Sci USA. 112:4334–4339. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lopez Sambrooks C, Baro M, Quijano A,
Narayan A, Cui W, Greninger P, Egan R, Patel A, Benes CH, Saltzman
WM and Contessa JN: Oligosaccharyltransferase inhibition overcomes
therapeutic resistance to EGFR tyrosine kinase inhibitors. Cancer
Res. 78:5094–5106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lau KS, Partridge EA, Grigorian A,
Silvescu CI, Reinhold VN, Demetriou M and Dennis JW: Complex
N-glycan number and degree of branching cooperate to regulate cell
proliferation and differentiation. Cell. 129:123–134. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Freitas Junior JC, Silva BR, de Souza
WF, de Araújo WM, Abdelhay ES and Morgado-Díaz JA: Inhibition of
N-linked glycosylation by tunicamycin induces E-cadherin-mediated
cell-cell adhesion and inhibits cell proliferation in
undifferentiated human colon cancer cells. Cancer Chemother
Pharmacol. 68:227–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peter Y, Comellas A, Levantini E, Ingenito
EP and Shapiro SD: Epidermal growth factor receptor and claudin-2
participate in A549 permeability and remodeling: Implications for
non-small cell lung cancer tumor colonization. Mol Carcinog.
48:488–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taniguchi N and Korekane H: Branched
N-glycans and their implications for cell adhesion, signaling and
clinical applications for cancer biomarkers and in therapeutics.
BMB Rep. 44:772–781. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishida H, Togayachi A, Sakai T, Iwai T,
Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al: A novel
beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which
synthesizes poly-N-acetyllactosamine, is dramatically upregulated
in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dall'Olio F, Malagolini N, di Stefano G,
Minni F, Marrano D and Serafini-Cessi F: Increased CMP-NeuAc:Gal
beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human
colorectal cancer tissues. Int J Cancer. 44:434–439. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Petretti T, Kemmner W, Schulze B and
Schlag PM: Altered mRNA expression of glycosyltransferases in human
colorectal carcinomas and liver metastases. Gut. 46:359–366. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dall'Olio F, Chiricolo M, Ceccarelli C,
Minni F, Marrano D and Santini D: Beta-galactoside alpha2,6
sialyltransferase in human colon cancer: Contribution of multiple
transcripts to regulation of enzyme activity and reactivity with
sambucus nigra agglutinin. Int J Cancer. 88:58–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dall'Olio F, Chiricolo M, Mariani E and
Facchini A: Biosynthesis of the cancer-related sialyl-alpha
2,6-lactosaminyl epitope in colon cancer cell lines expressing
beta-galactoside alpha 2,6-sialyltransferase under a constitutive
promoter. Eur J Biochem. 268:5876–5884. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Royer C and Lu X: Epithelial cell
polarity: A major gatekeeper against cancer? Cell Death Differ.
18:1470–1477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Halaoui R and McCaffrey L: Rewiring cell
polarity signaling in cancer. Oncogene. 34:939–950. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bouchagier KA, Assimakopoulos SF, Karavias
DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D,
Scopa CD and Tsamandas AC: Expression of claudins-1, −4, −5, −7 and
occludin in hepatocellular carcinoma and their relation with
classic clinicopathological features and patients' survival. In
Vivo. 28:315–326. 2014.PubMed/NCBI
|
|
34
|
Katayama A, Handa T, Komatsu K, Togo M,
Horiguchi J, Nishiyama M and Oyama T: Expression patterns of
claudins in patients with triple-negative breast cancer are
associated with nodal metastasis and worse outcome. Pathol Int.
67:404–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pinho SS, Figueiredo J, Cabral J, Carvalho
S, Dourado J, Magalhães A, Gärtner F, Mendonfa AM, Isaji T, Gu J,
et al: E-cadherin and adherens-junctions stability in gastric
carcinoma: Functional implications of glycosyltransferases
involving N-glycan branching biosynthesis,
N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta.
1830:2690–2700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bücker R, Krug SM, Fromm A, Nielsen HL,
Fromm M, Nielsen H and Schulzke JD: Campylobacter fetus impairs
barrier function in HT-29/B6 cells through focal tight junction
alterations and leaks. Ann N Y Acad Sci. 1405:189–201. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zeissig S, Bürgel N, Günzel D, Richter J,
Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M and
Schulzke JD: Changes in expression and distribution of claudin 2, 5
and 8 lead to discontinuous tight junctions and barrier dysfunction
in active crohn's disease. Gut. 56:61–72. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nami B, Donmez H and Kocak N:
Tunicamycin-induced endoplasmic reticulum stress reduces in vitro
subpopulation and invasion of CD44+/CD24−
phenotype breast cancer stem cells. Exp Toxicol Pathol. 68:419–426.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Capaldo CT and Nusrat A: Claudin
switching: Physiological plasticity of the tight junction. Semin
Cell Dev Biol. 42:22–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Findley MK and Koval M: Regulation and
roles for claudin-family tight junction proteins. IUBMB Life.
61:431–437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koval M: Differential pathways of claudin
oligomerization and integration into tight junctions. Tissue
Barriers. 1:e245182013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hewitt KJ, Agarwal R and Morin PJ: The
claudin gene family: Expression in normal and neoplastic tissues.
BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kwon MJ: Emerging roles of claudins in
human cancer. Int J Mol Sci. 14:18148–18180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dias K, Dvorkin-Gheva A, Hallett RM, Wu Y,
Hassell J, Pond GR, Levine M, Whelan T and Bane AL: Claudin-low
breast cancer; clinical & pathological characteristics. PLoS
One. 12:e01686692017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Oliveira SS and Morgado-Díaz JA: Claudins:
Multifunctional players in epithelial tight junctions and their
role in cancer. Cell Mol Life Sci. 64:17–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Iacobuzio-Donahue CA, Maitra A, Shen-Ong
GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth
MA, Cameron JL, et al: Discovery of novel tumor markers of
pancreatic cancer using global gene expression technology. Am J
Pathol. 160:1239–1249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Levine EA, Votanopoulos KI, Qasem SA,
Philip J, Cummins KA, Chou JW, Ruiz J, D'Agostino R, Shen P and
Miller LD: Prognostic molecular subtypes of low-grade cancer of the
appendix. J Am Coll Surg. 222:493–503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ashkani J and Naidoo KJ:
Glycosyltransferase gene expression profiles classify cancer types
and propose prognostic subtypes. Sci Rep. 6:264512016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thanki K, Nicholls ME, Gajjar A, Senagore
AJ, Qiu S, Szabo C, Hellmich MR and Chao C: Consensus molecular
subtypes of colorectal cancer and their clinical implications. Int
Biol Biomed J. 3:105–111. 2017.PubMed/NCBI
|
|
50
|
Cherradi S, Martineau P, Gongora C and Del
Rio M: Claudin gene expression profiles and clinical value in
colorectal tumors classified according to their molecular subtype.
Cancer Manag Res. 11:1337–1348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Vogel C and Marcotte EM: Insights into the
regulation of protein abundance from proteomic and transcriptomic
analyses. Nat Rev Genet. 13:227–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Koussounadis A, Langdon SP, Um IH,
Harrison DJ and Smith VA: Relationship between differentially
expressed mRNA and mRNA-protein correlations in a xenograft model
system. Sci Rep. 5:107752015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dunne PD, McArt DG, Bradley CA, O'Reilly
PG, Barrett HL, Cummins R, O'Grady T, Arthur K, Loughrey MB, Allen
WL, et al: Challenging the cancer molecular stratification dogma:
Intratumoral heterogeneity undermines consensus molecular subtypes
and potential diagnostic value in colorectal cancer. Clin Cancer
Res. 22:4095–4104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Prat A, Pineda E, Adamo B, Galván P,
Fernández A, Gaba L, Díez M, Viladot M, Arance A and Muñoz M:
Clinical implications of the intrinsic molecular subtypes of breast
cancer. Breast. 24 (Suppl 2):S26–S35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
De Sousa E, Melo F, Wang X, Jansen M,
Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van
Leersum R, et al: Poor-prognosis colon cancer is defined by a
molecularly distinct subtype and develops from serrated precursor
lesions. Nat Med. 19:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Trinh A, Trumpi K, De Sousa E, Melo F,
Wang X, de Jong JH, Fessler E, Kuppen PJ, Reimers MS, Swets M, et
al: Practical and robust identification of molecular subtypes in
colorectal cancer by immunohistochemistry. Clin Cancer Res.
23:387–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Carvalho S, Reis CA and Pinho SS:
Cadherins glycans in cancer: Sweet players in a bitter process.
Trends Cancer. 2:519–531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Contessa JN, Bhojani MS, Freeze HH, Ross
BD, Rehemtulla A and Lawrence TS: Molecular imaging of N-linked
glycosylation suggests glycan biosynthesis is a novel target for
cancer therapy. Clin Cancer Res. 16:3205–3214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
de Freitas Junior JC and Morgado-Díaz JA:
The role of N-glycans in colorectal cancer progression: Potential
biomarkers and therapeutic applications. Oncotarget. 7:19395–19413.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Anugraham M, Jacob F, Nixdorf S,
Everest-Dass AV, Heinzelmann-Schwarz V and Packer NH: Specific
glycosylation of membrane proteins in epithelial ovarian cancer
cell lines: Glycan structures reflect gene expression and DNA
methylation status. Mol Cell Proteomics. 13:2213–2232. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kannagi R, Yin J, Miyazaki K and Izawa M:
Current relevance of incomplete synthesis and neo-synthesis for
cancer-associated alteration of carbohydrate
determinants-Hakomori's concepts revisited. Biochim Biophys Acta.
1780:525–531. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Meany DL and Chan DW: Aberrant
glycosylation associated with enzymes as cancer biomarkers. Clin
Proteomics. 8:72011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu L, Yan B, Huang J, Gu Q, Wang L, Fang
M, Jiao J and Yue X: The identification and characterization of
novel N-glycan-based biomarkers in gastric cancer. PLoS One.
8:e778212013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Qin R, Zhao J, Qin W, Zhang Z, Zhao R, Han
J, Yang Y, Li L, Wang X, Ren S, et al: Discovery of non-invasive
glycan biomarkers for detection and surveillance of gastric cancer.
J Cancer. 8:1908–1916. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kim YS, Ahn YH, Song KJ, Kang JG, Lee JH,
Jeon SK, Kim HC, Yoo JS and Ko JH: Overexpression and
β-1,6-N-acetylglucosaminylation-initiated aberrant glycosylation of
TIMP-1: A ‘double whammy’ strategy in colon cancer progression. J
Biol Chem. 287:32467–32478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Murata K, Miyoshi E, Kameyama M, Ishikawa
O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S,
et al: Expression of N-acetylglucosaminyltransferase V in
colorectal cancer correlates with metastasis and poor prognosis.
Clin Cancer Res. 6:1772–1777. 2000.PubMed/NCBI
|
